219 related articles for article (PubMed ID: 23963825)
61. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.
Zhang Y; Guo X; Li Z; Li B; Li Z; Li R; Guo Q; Xiong L; Yu L; Zhao J; Lin N
RNA Biol; 2015; 12(6):643-57. PubMed ID: 25985117
[TBL] [Abstract][Full Text] [Related]
62. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway.
Wu X; Liu P; Zhang H; Li Y; Salmani JM; Wang F; Yang K; Fu R; Chen Z; Chen B
BMC Cancer; 2017 Feb; 17(1):147. PubMed ID: 28222771
[TBL] [Abstract][Full Text] [Related]
63. The aberrant activation of Wnt pathway caused by β-catenin mutation and its prognostic significance in NK/T-cell lymphoma.
Qin BB; Tang DF; Ni ML; Gao W; Zhang MZ
Neoplasma; 2019 Jan; 66(1):20-27. PubMed ID: 30509083
[TBL] [Abstract][Full Text] [Related]
64. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
Guo S; Xu X; Tang Y; Zhang C; Li J; Ouyang Y; Ju J; Bie P; Wang H
Cancer Lett; 2014 Mar; 344(1):40-46. PubMed ID: 24252251
[TBL] [Abstract][Full Text] [Related]
65. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.
Liao WT; Li TT; Wang ZG; Wang SY; He MR; Ye YP; Qi L; Cui YM; Wu P; Jiao HL; Zhang C; Xie YJ; Wang JX; Ding YQ
Clin Cancer Res; 2013 Sep; 19(17):4662-72. PubMed ID: 23846336
[TBL] [Abstract][Full Text] [Related]
66. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
67. Upregulation of AKT1 and downregulation of AKT3 caused by dysregulation of microRNAs contributes to pathogenesis of hemangioma by promoting proliferation of endothelial cells.
Lu S; Chen L; Tang L
J Cell Physiol; 2019 Nov; 234(11):21342-21351. PubMed ID: 31074018
[TBL] [Abstract][Full Text] [Related]
68. Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis.
Ferraz C; Lorenz S; Wojtas B; Bornstein SR; Paschke R; Eszlinger M
J Clin Endocrinol Metab; 2013 Jan; 98(1):E8-16. PubMed ID: 23144465
[TBL] [Abstract][Full Text] [Related]
69. Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.
Ng SB; Yan J; Huang G; Selvarajan V; Tay JL; Lin B; Bi C; Tan J; Kwong YL; Shimizu N; Aozasa K; Chng WJ
Blood; 2011 Nov; 118(18):4919-29. PubMed ID: 21921041
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.
Paik JH; Jang JY; Jeon YK; Kim WY; Kim TM; Heo DS; Kim CW
Clin Cancer Res; 2011 Jul; 17(14):4761-71. PubMed ID: 21610143
[TBL] [Abstract][Full Text] [Related]
71. Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.
Takahara M; Nagato T; Kishibe K; Ueda S; Komabayashi Y; Yamashina M; Takahashi K; Harabuchi Y
Hematol Oncol; 2017 Jun; 35(2):158-162. PubMed ID: 26563973
[TBL] [Abstract][Full Text] [Related]
72. Upregulation of the miR-212/132 cluster suppresses proliferation of human lung cancer cells.
Jiang X; Chen X; Chen L; Ma Y; Zhou L; Qi Q; Liu Y; Zhang S; Luo J; Zhou X
Oncol Rep; 2015 Feb; 33(2):705-12. PubMed ID: 25435090
[TBL] [Abstract][Full Text] [Related]
73. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
Gao J; Zhang JY; Li YH; Ren F
Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
[TBL] [Abstract][Full Text] [Related]
74. CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.
Klein S; Abraham M; Bulvik B; Dery E; Weiss ID; Barashi N; Abramovitch R; Wald H; Harel Y; Olam D; Weiss L; Beider K; Eizenberg O; Wald O; Galun E; Pereg Y; Peled A
Cancer Res; 2018 Mar; 78(6):1471-1483. PubMed ID: 29259008
[TBL] [Abstract][Full Text] [Related]
75. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma.
Zhu FQ; Zeng L; Tang N; Tang YP; Zhou BP; Li FF; Wu WG; Zeng XB; Peng SS
Oncol Res; 2016 Oct; 24(6):415-427. PubMed ID: 28281962
[TBL] [Abstract][Full Text] [Related]
76. LMP1-miR-146a-CXCR4 axis regulates cell proliferation, apoptosis and metastasis.
Wang W; Zhang Y; Liu W; Xiao H; Zhang Q; Wang J; Luo B
Virus Res; 2019 Sep; 270():197654. PubMed ID: 31299195
[TBL] [Abstract][Full Text] [Related]
77. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.
Lerner M; Harada M; Lovén J; Castro J; Davis Z; Oscier D; Henriksson M; Sangfelt O; Grandér D; Corcoran MM
Exp Cell Res; 2009 Oct; 315(17):2941-52. PubMed ID: 19591824
[TBL] [Abstract][Full Text] [Related]
78. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.
Bandi N; Vassella E
Mol Cancer; 2011 May; 10():55. PubMed ID: 21575235
[TBL] [Abstract][Full Text] [Related]
79. Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.
Wang J; Zhang X; Shi J; Cao P; Wan M; Zhang Q; Wang Y; Kridel SJ; Liu W; Xu J; Zhang Q; Sui G
Oncotarget; 2016 Nov; 7(48):78566-78576. PubMed ID: 27713175
[TBL] [Abstract][Full Text] [Related]
80. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.
Harabuchi Y; Takahara M; Kishibe K; Nagato T; Kumai T
Front Pediatr; 2019; 7():141. PubMed ID: 31041299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
